S&CO Inc. Has $16.39 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

S&CO Inc. lowered its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.1% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 28,037 shares of the healthcare conglomerate’s stock after selling 1,195 shares during the period. UnitedHealth Group makes up about 1.1% of S&CO Inc.’s holdings, making the stock its 26th biggest position. S&CO Inc.’s holdings in UnitedHealth Group were worth $16,392,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Kathleen S. Wright Associates Inc. acquired a new stake in UnitedHealth Group in the third quarter worth $27,000. Global Wealth Strategies & Associates increased its position in UnitedHealth Group by 152.4% in the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock valued at $31,000 after buying an additional 32 shares in the last quarter. Macroview Investment Management LLC grew its stake in UnitedHealth Group by 671.4% in the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after acquiring an additional 47 shares during the period. West Financial Advisors LLC bought a new position in shares of UnitedHealth Group in the 3rd quarter worth $32,000. Finally, Bbjs Financial Advisors LLC bought a new stake in UnitedHealth Group during the 2nd quarter valued at $31,000. 87.86% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the stock. TD Cowen boosted their target price on shares of UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a research report on Friday, October 18th. UBS Group dropped their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Barclays dropped their price objective on UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating on the stock in a research note on Tuesday, October 22nd. Morgan Stanley lowered their target price on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. Finally, Royal Bank of Canada dropped their target price on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 16th. Three analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $615.53.

UnitedHealth Group Stock Down 0.2 %

UNH opened at $592.23 on Friday. The company has a market cap of $545.02 billion, a PE ratio of 38.58, a price-to-earnings-growth ratio of 1.74 and a beta of 0.58. The company has a 50 day moving average of $582.84 and a 200 day moving average of $549.52. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company has a current ratio of 0.91, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. During the same quarter last year, the company earned $6.56 EPS. The firm’s revenue was up 9.2% compared to the same quarter last year. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be issued a $2.10 dividend. The ex-dividend date of this dividend is Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.42%. UnitedHealth Group’s payout ratio is currently 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.